BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16582100)

  • 1. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas.
    Nowak K; Kerl K; Fehr D; Kramps C; Gessner C; Killmer K; Samans B; Berwanger B; Christiansen H; Lutz W
    Nucleic Acids Res; 2006; 34(6):1745-54. PubMed ID: 16582100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
    Ochiai H; Takenobu H; Nakagawa A; Yamaguchi Y; Kimura M; Ohira M; Okimoto Y; Fujimura Y; Koseki H; Kohno Y; Nakagawara A; Kamijo T
    Oncogene; 2010 May; 29(18):2681-90. PubMed ID: 20190806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
    Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG
    FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F proteins regulate MYCN expression in neuroblastomas.
    Strieder V; Lutz W
    J Biol Chem; 2003 Jan; 278(5):2983-9. PubMed ID: 12438307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
    Muth D; Ghazaryan S; Eckerle I; Beckett E; Pöhler C; Batzler J; Beisel C; Gogolin S; Fischer M; Henrich KO; Ehemann V; Gillespie P; Schwab M; Westermann F
    Cancer Res; 2010 May; 70(9):3791-802. PubMed ID: 20424123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycomb group protein Bmi1 promotes hematopoietic cell development from embryonic stem cells.
    Ding X; Lin Q; Ensenat-Waser R; Rose-John S; Zenke M
    Stem Cells Dev; 2012 Jan; 21(1):121-32. PubMed ID: 21545235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
    Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
    Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.
    Kramps C; Strieder V; Sapetschnig A; Suske G; Lutz W
    J Biol Chem; 2004 Feb; 279(7):5110-7. PubMed ID: 14645238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
    Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
    Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMI1 sustains human glioblastoma multiforme stem cell renewal.
    Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
    J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract.
    Tateishi K; Ohta M; Kanai F; Guleng B; Tanaka Y; Asaoka Y; Tada M; Seto M; Jazag A; Lianjie L; Okamoto M; Isayama H; Tada M; Yoshida H; Kawabe T; Omata M
    Clin Cancer Res; 2006 Dec; 12(23):6960-6. PubMed ID: 17145814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
    Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
    Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells.
    Venugopal C; Li N; Wang X; Manoranjan B; Hawkins C; Gunnarsson T; Hollenberg R; Klurfan P; Murty N; Kwiecien J; Farrokhyar F; Provias JP; Wynder C; Singh SK
    Stem Cell Res; 2012 Mar; 8(2):141-53. PubMed ID: 22265735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylation-dependent nuclear arrangement and recruitment of BMI1 protein to UV-damaged chromatin.
    Sustáčková G; Kozubek S; Stixová L; Legartová S; Matula P; Orlova D; Bártová E
    J Cell Physiol; 2012 May; 227(5):1838-50. PubMed ID: 21732356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.
    Vandesompele J; Edsjö A; De Preter K; Axelson H; Speleman F; Påhlman S
    Oncogene; 2003 Jan; 22(3):456-60. PubMed ID: 12545167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
    Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
    Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
    Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
    Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2f6 and Bmi1 cooperate in axial skeletal development.
    Courel M; Friesenhahn L; Lees JA
    Dev Dyn; 2008 May; 237(5):1232-42. PubMed ID: 18366140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMI1'S maintenance of the proliferative capacity of laryngeal cancer stem cells.
    Chen H; Zhou L; Dou T; Wan G; Tang H; Tian J
    Head Neck; 2011 Aug; 33(8):1115-25. PubMed ID: 21755556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.